Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation.

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions
Bacteremia
Trial Locations (16)

1039

Sanatorio Franchin, Buenos Aires

1118

Hospital Alemán, Buenos Aires

1282

Hospital de Infecciosas Francisco Javier Muñiz, Buenos Aires

1425

Hospital Italiano de Buenos Aires, Buenos Aires

1437

Hospital Médico Policial Churruca Visca, Buenos Aires

1629

Hospital Universitario Austral, Pilar

1641

"Hospital Municipal Central de San Isidro Dr. Melchor Ángel Posse", San Isidro

1706

Hospital Interzonal General de Agudos ''Profesor Dr. Luis Güemes'', Haedo

1842

Hospital de Alta Complejidad del Bicentenario Esteban Echeverria, Monte Grande

1872

Hospital Presidente Perón, Sarandí

2001

Hospital Italiano Rosario, Rosario

3000

Hospital José Bernardo Iturraspe, Santa Fe

Hospital José María Cullen, Santa Fe

3600

Hospital Interdistrital Evita, Formosa

5016

Hospital Privado Universitario de Córdoba, Córdoba

8000

Hospital Municipal de Agudos Dr. Leónidas Lucero, Bahía Blanca

All Listed Sponsors
lead

Hospital Italiano de Buenos Aires

OTHER

NCT06419296 - Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation. | Biotech Hunter | Biotech Hunter